Condition category
Circulatory System
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Background and study aims
Measuring myocardial (heart muscle) strain is of growing interest in cardiovascular magnetic resonance (CMR) imaging for the detection of subclinical myocardial dysfunction in heart disease. The aim of this study is to assess the age and gender-related reference values of myocardial strain in healthy adults and to evaluate the influence of field strength and postprocessing software.

Who can participate?
Data collected in previous studies using CMR were analysed in this study (healthy volunteers aged over 18)

What does the study involve?
CMR data is analysed to find differences in the results of the analysis using different software and different strengths of scanning devices.

What are the possible benefits and risks of participating?

Where is the study run from?
Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité University Medicine Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany

When is the study starting and how long is it expected to run for?
January 2018 to July 2019

Who is funding the study?
Charité – Universitätsmedizin Berlin (Charité University Medicine Berlin) (Germany)

Who is the main contact?
Prof. Jeanette Schulz-Menger

Trial website

Contact information



Primary contact

Prof Jeanette Schulz-Menger


Contact details

Charité University Medicine Berlin Campus Buch Working Group Kardiale MRT Lindenberger Weg 80

Additional identifiers

EudraCT number

Nil known number

Nil known

Protocol/serial number

Nil known

Study information

Scientific title

Quantification of myocardial strain assessed by Cardiovascular Magnetic Resonance feature tracking in healthy subjects – influence of post-processing


Study hypothesis

A retrospective study of strain analysis to establish standards for image acquisition and interpretation and to add further knowledge in this regard by analysing the influence of scanner field strength and analysis software package on age- and gender-related reference values of myocardial strain

Ethics approval

Approved 04/11/2010 and 17/07/2014, ethical committee of the Charité Medical Faculty (Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany; Tel: +49 (0)30 450 517 222; Email:, ref: (EA2/077/10), EA1/058/13, DOI, 0.1161/CIRCIMAGING.116.005242

Study design

Retrospective proof of concept trial

Primary study design


Secondary study design

Cohort study

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details to request a patient information sheet


Myocardial strain in healthy volunteers


The researchers screened healthy subjects, who were prospectively examined in former studies. The ethical committee Charite approved all of the studies. All participants were enrolled after informed consent was obtained.

CMR was applied at a 1.5 and 3 T Scanner (Siemens Healthcare, Erlangen, Germany) using a 32 channel surface coil. Cine imaging is performed applying state of the art steady state precession sequences to determine the global cardiac performance in three long axis and short axis.

It is a retrospective trial to evaluate the reference values of myocardial strain applying cardiovascular magnetic resonance (CMR) by analysing the influence of scanner field strength, analysis software package, age- and gender-related factors. This proof of concept trial is intended to extend the indications for CMR.

Subjects were divided into three age groups: group 1 aged < 35 years, group 2 aged 35-55 years and group 3 aged > 55 years

Only volunteers with similar cine protocols were included. Feature tracking analysis was performed using CVI42 software (prototype version 5.3.0, Circle Cardiovascular Imaging Inc., Calgary, Canada). All images were additionally analyzed with TomTec Image Arena (version, TomTec Imaging Systems GmbH, Unterschleissheim, Germany).

Statistical analyses were performed using IBM SPSS Statistic version 23 (IBM, Armonk, US). The researchers calculated mean values and standard deviation (SD) for demographic parameters, LV function and strain measurements. Volumes were indexed to body surface area (BSA) and height. Non-parametric Mann-Whitney-U-Test for unpaired samples was used for comparisons of strain parameters between gender, analysis software and field strength. Age-related differences were analyzed using the non-parametric Kruskal-Wallis-Test. Differences were considered statistically significant at p < 0.05.

Intervention type



Drug names

Primary outcome measure

1. Longitudinal strain assessed in three long-axis views: 4CV, 3CV and 2CV
2. Circumferential strain and radial strain assessed short-axis full coverage
Measured using CMR at a single timepoint

Secondary outcome measures

There were no secondary outcome measures

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Healthy male and female aged > 18 years
2. Preserved left ventricular ejection fraction in echocardiography
3. Willingness to undergo CMR
4. Willingness and ability to follow directions and complete all study procedures as specified in the protocol

Participant type

Healthy volunteer

Age group




Target number of participants

The researchers screened 243 healthy subjects, 67 healthy subjects were included

Total final enrolment


Participant exclusion criteria

1. Any known cardiovascular risk factor
2. History of cardiac disease
3. Impaired LV ejection fraction (LVEF) (< 55%)
4. Pathologic findings in CMR
5. Incomplete CMR data for feature tracking analysis (less than three long axis and three short axis views) led to exclusion

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

Charité University Medicine Berlin
Working Group Kardiale MRT Lindenberger Weg 80

Sponsor information


Charité University Medicine Berlin

Sponsor details

Working Group Kardiale MRT
Lindenberger Weg 80

Sponsor type




Funder type


Funder name

Charité – Universitätsmedizin Berlin

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Results of this study shall be published in a high-ranking peer-reviewed journal.

IPD sharing statement
The datasets generated during and/or analysed during the current study are not expected to be made available due to reasons of data protection laws in Germany. However, upon request methodology and dataset structure can be shared.

Intention to publish date


Participant level data

Not expected to be available

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

10/07/2020: The intention to publish date was changed from 30/11/2019 to 30/10/2020. 18/09/2019: Trial's existence confirmed by ethics committee.